Myelination of the central nervous system (CNS) by oligodendrocytes (OLs) is essential for its development and function. Myelin sheaths develop in the CNS as OLs undergo terminal differentiation, implicating OL differentiation as a crucial event for CNS myelination. OL differentiation also represents a key rate-limiting step of remyelination in pathological conditions. Transcriptional regulation plays a pivotal role in the differentiation of OLs, which is a team effort of trans-acting factors and cis-regulatory DNA elements such as enhancers. Much work has been devoted to trans-acting factors, identifying important transcription factors for OL development. In contrast, relatively little is known about enhancers that orchestrate the differentiation of OLs. Further, the role of OL enhancer variants in the etiology of CNS disorders remains poorly understood. Building upon our innovative preliminary study, this grant intends to address these critical issues. Sox10 is a high-mobility group transcription factor essential for OL differentiation and CNS myelination. Yet, the identity of OL enhancers that regulate Sox10 expression remains elusive.
Aim I intends to reveal an intricate network of OL enhancers that governs Sox10 expression for timely OL differentiation. We found that 75 single nucleotide polymorphisms (SNPs) associated with CNS traits are mapped to putative OL enhancers, prompting us to hypothesize that CNS trait SNPs may exert their effects by impacting OL enhancers and the property of OL lineage cells. As a proof of principle, Aim II will examine whether this is true for 3 CNS trait SNPs. In sum, this study will elucidate the understudied, yet crucial role of OL enhancers in CNS development and disease.

Public Health Relevance

Nerve axons in the brain and spinal cord are wrapped by myelin sheaths, which is essential for their development and function. Myelin sheaths develop as oligodendrocytes undergo differentiation, implicating oligodendrocyte differentiation as a crucial event for myelination. This project will elucidate the molecular events underlying oligodendrocyte differentiation, providing critical insights into the development and disease of the central nervous system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21NS102558-02
Application #
9659387
Study Section
Cellular and Molecular Biology of Glia Study Section (CMBG)
Program Officer
Morris, Jill A
Project Start
2018-04-01
Project End
2021-03-31
Budget Start
2019-04-01
Budget End
2021-03-31
Support Year
2
Fiscal Year
2019
Total Cost
Indirect Cost
Name
State University of New York at Buffalo
Department
Biochemistry
Type
Schools of Medicine
DUNS #
038633251
City
Amherst
State
NY
Country
United States
Zip Code
14228